Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions ...

As telehealth promotes GLP-1s for addiction, experts worry about fragmented care, and exposing patients to unknown risks.

For 50 years, doctors shrugged about the disease running through Miranda Pappas’ family. Then she discovered something.

Today, a look at FDA’s final guidance on drug-related apps and what it means for the future of digital therapeutics. Plus the ...

The surprising departure of Calley Means comes just before an election that may serve as a referendum on the MAHA movement.

This is the online version of Adam’s Biotech Scorecard, a weekly newsletter featuring exclusive, spicy analysis on the ...

A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% ...

MAHA allies and nutrition experts want the Trump administration to act on ultra-processed foods before the elections.

Working-age U.S. adults without health insurance rose in 2026. Half of all uninsured people did not seek needed care because ...

U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to ...

An endocrinologist who had long served in the American Diabetes Association's leadership is out without explanation.

An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease ...